James Related News
Deconstructing diabetes – why one size does not fit all
MEDIA RELEASE:
30 Nov 2011
Professor David James, Head of the Diabetes and Obesity Program at Garvan, believes it’s time to draw attention to the many things we don’t yet know about the complex metabolic disease we call ‘Type 2 diabetes’, and to the oversimplifications that abound in discussion of future treatments.
Exploring the amazing little world of the fat cell
MEDIA RELEASE:
28 Sep 2011
For the first time, Australian scientists have detailed the proteins, or functional molecules, inside and around the ‘plasma membrane’ of a fat cell, the permeable barrier between the cell’s inner workings and the rest of the body. Understanding the way that proteins function at the surface of these cells will help us unravel some of the complexities underlying Type 2 diabetes.
Garvan Scientists acknowledged on World Diabetes Day
14 Nov 2010
Garvan diabetes research has been recognised by the Diabetes Australia Research Trust, which announced that several Garvan scientists would be receiving significant research support over the coming two years.
Sean Humphrey wins 2010 Castle Harlan Award
26 Oct 2010
Sean Humphrey has received the $10,000 USD Castle Harlan Award for being the most outstanding early career PhD student at the Garvan Institute in 2010. His research uses the latest mass spectrometry technologies to study Type 2 diabetes as a system.
Setting the record straight on weight loss
MEDIA RELEASE:
06 Jan 2010
It’s time to set the record straight. The only reliable way to lose weight is to eat less or exercise more. Preferably both. So why bother to state the obvious? Because a body of scientific literature has arisen over recent years, suggesting that fat oxidation – burning the fats we eat as opposed to the carbohydrates – is enough to promote fat loss. It isn’t.
The free radical that triggers insulin resistance and Type 2 diabetes
MEDIA RELEASE:
28 Sep 2009
Garvan scientists have found that overeating may stimulate the conversion of the oxygen in the air we breathe into toxic free radicals, leading to insulin resistance and Type 2 diabetes. Until now, no-one has identified the central mechanism, or cellular switch, that initiates insulin resistance.
Will bitter melon in a bottle live up to its promise?
MEDIA RELEASE:
21 Jan 2009
Diabetes researchers at Garvan have received nearly $300,000 in Commonwealth funding to advance their research into the therapeutic properties of bitter melon, a vegetable and traditional Chinese medicine.
Completely novel action of insulin unveiled
MEDIA RELEASE:
05 Nov 2008
Freddy Yip, a Garvan PhD student, has found a significant missing link in our knowledge about insulin and how it helps cells absorb glucose. Freddy's finding reveals an important molecular mechanism activated by insulin.
Research agreement to reveal secret lives of cells
MEDIA RELEASE:
06 Aug 2008
Garvan and CSIRO have signed a three-year collaboration agreement to investigate important cellular processes, including those impaired by diseases such as diabetes. They will be using a new computer vision system they developed jointly to watch intricate cellular processes in real time.
A tonne of bitter melon produces sweet results for diabetes
MEDIA RELEASE:
22 Mar 2008
Teams from the Garvan Institute of Medical Research and the Shanghai Institute of Materia Medica pulped roughly a tonne of fresh bitter melon and extracted four very promising bioactive components that explain why it is has been used in Chinese medicine for hundreds of years. It now promises to be an effective treatment for Type 2 diabetes.
New Fellowship Strengthens Garvan Potential to find a cure for Type 2 diabetes
MEDIA RELEASE:
06 Dec 2007
We are very pleased to announce the establishment of the GlaxoSmithKline Don Chisholm Fellowship for Diabetes Research – a position dedicated to vital research into the causes, processes and treatments for Type 2 diabetes, one of Australia’s most common and serious diseases.
Professor David James elected Fellow of the Australian Academy of Science
15 Mar 2007
The Director of Garvan’s Diabetes and Obesity Research Program, Professor David James, has been elected Fellow of the Australian Academy of Science in recognition of his outstanding contributions to science.
Traditional Chinese Medicine for diabetes has scientific backing
01 Aug 2006
Reports of a traditional Chinese medicine having beneficial effects for people suffering from type 2 diabetes now has some scientific evidence to back up the claims.
Garvan student wins prestigious University Medal
01 Feb 2006
Yvonne Ng, a 2005 Honours student in the Diabetes and Obesity Research Program, has won the UNSW University Medal for Molecular Biology
